Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Entertainment
  • General
  • Large Cap
  • News
  • Tech
  • Trading Ideas

How Much Titanium Is Really In Apple’s New iPhone 15 Pro Models?

By AJ Fabino
October 5, 3:49 PM
According to a popular YouTuber, Apple’s new iPhone 15 Pro, priced at $999, and its $1,199 sibling, the…

AAPL

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • Equities
  • Large Cap
  • Markets
  • News

Clorox Faces Challenges from Cyberattack; Analyst Predicts Slow Recovery Until FY25

By Lekha Gupta
October 5, 3:11 PM
Raymond James analyst Olivia Tong downgraded Clorox Co (NYSE: CLX) to Market Perform from Outperform and 

CLX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News
  • Penny Stocks
  • Small Cap

Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute

By Vandana Singh
October 5, 3:04 PM
Biotech firm Promosome has agreed to end the lawsuit, which accused the COVID-19 vaccine manufacturers, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX), of patent infrin

ABUS

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Why Is Neurocrine Biosciences Shares Trading Higher Today?

By Vandana Singh
October 5, 2:38 PM
Neurocrine Biosciences Inc (NASDAQ: NBIX) released topline data from the Phase 3 CAHtalyst Pediatric Study of crinecerfont in children and adolescents with classic congenital adrenal hyperplasia (CAH) due to 

NBIX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Broad U.S. Equity ETFs
  • ETFs
  • Large Cap
  • Tech

How The ‘January Effect’ Could Spark Tech Stock Renaissance In October, Q4

By Piero Cingari
October 5, 12:46 PM
Technology stocks are likely to have a high probability of rallying in the just-started month of October and…

ONEQ

Read More
1 minute read
  • Dividends
  • Earnings
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • News

Duncan Hines Parent ConAgra Brands’ Q1: Flat Sales, EPS Beat, Inflation-Driven Pricing, Reaffirmed FY24 Guidance & More

By Lekha Gupta
October 5, 9:36 AM
ConAgra Brands Inc (NYSE: CAG) reported Q1 FY24 sales of $2.90 billion, flat Y/Y, 

CAG

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck’s Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study

By Vandana Singh
October 5, 9:35 AM
Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant treatment of localized muscle-invasive urothelial carcinoma and 

ALPMF

Read More
2 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • Large Cap
  • Markets
  • News

Novo Nordisk’s Wegovy Success Uplifts Denmark’s Economy And Reputation, But With Caution

By Vandana Singh
October 5, 9:01 AM
Novo Nordisk A/S's (NYSE: NVO) remarkable success with its weight-loss treatment, Wegovy, is not only a cause for celebration but also a source of 

LVMHF

Read More
1 minute read
  • Biotech
  • General
  • Government
  • Health Care
  • Large Cap
  • News

No Merck’s COVID-19 Pill – US Government Ceases Free Distribution

By Vandana Singh
October 5, 8:59 AM
The U.S. government is set to cease the distribution of free doses of Merck & Co Inc's (NYSE: MRK) COVID-19 antiviral treatment Lagevrio (molnupiravir), by mid-November, shifting its availability to the commercial market. 

MRK

Read More
2 minute read
  • Equities
  • Guidance
  • Large Cap
  • Markets
  • Movers
  • News

Why Bleach And Cleaning Products Maker Clorox’s Shares Declining Today?

By Lekha Gupta
October 5, 7:19 AM
Clorox Co (NYSE: CLX) shares are trading lower after it reported 

CLX

Posts pagination

Previous 1 … 197 198 199 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service